GLP-1 receptor agonists are transforming treatment of diabetes and obesity, but their use in correctional settings remains limited. This session reviews the clinical evidence for GLP-1s, their potential role in other conditions like substance use disorders, and challenges in utilizing them in jails and prisons. Attendees will gain insight into cost, access, and medical necessity considerations, as well as strategies for addresses the nuances of GLP-1 use.

Educational Objectives

• Describe the mechanism, indications, and clinical efficacy of GLP-1 receptor agonists
• Identify the challenges and considerations for prescribing GLP-1s in correctional facilities
• Discuss emerging research on new indications for GLP-1s and the implications for correctional health care

Level:Intermediate